Lexicon Pharmaceuticals
LXRX
LXRX
119 hedge funds and large institutions have $418M invested in Lexicon Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 30 increasing their positions, 31 reducing their positions, and 20 closing their positions.
Holders
119
Holders Change
+13
Holders Change %
+12.26%
% of All Funds
1.73%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
34
Increased
30
Reduced
31
Closed
20
Calls
$14.3M
Puts
$1.26M
Net Calls
+$13M
Net Calls Change
+$13M
Top Buyers
| 1 |
1
Fidelity Investments
Boston,
Massachusetts
|
$33.3M |
| 2 |
O
2
OrbiMed
New York
|
$8.5M |
| 3 |
SSA
3
Schonfeld Strategic Advisors
New York
|
$5.35M |
| 4 |
CSS
4
Cubist Systematic Strategies
Stamford,
Connecticut
|
$3.37M |
| 5 |
5
BlackRock
New York
|
$18.5M |
Top Sellers
| 1 |
BI
1
BVF Inc
San Francisco,
California
|
$4.05M |
| 2 |
2
JPMorgan Chase & Co
New York
|
$216K |
| 3 |
3
Morgan Stanley
New York
|
$586K |
| 4 |
4
Millennium Management
New York
|
$1.28M |
| 5 |
5
Citadel Advisors
Miami,
Florida
|
$323K |
